0 In focus: Tuberculosis
World Tuberculosis Day 2018 (March 24th) is an annual event aiming to raise public awareness around the health, economic and…
Browsing: Bacterial > Tuberculosis
0 N-TB – first-of-kind app launched for nutritional assessment and counselling of tuberculosis patients
World TB Day has seen the launch of the N-TB app, a first-of-kind tool to help healthcare providers in the nutritional assessment and counselling of adult patients with tuberculosis.
0 HIV and TB: the ongoing challenge of the two epidemics
TB and HIV are two intertwined infective challenges for global health and therefore they need to be addressed with an integrated approach.
0 #TalkTB – Catch up on the Twitter chat for World TB Day
We look at some of the highlights of our Twitter chat (#TalkTB), where we questioned Madhukar Pai, Nandita Venkatesan and Jacob Creswell about all things tuberculosis – from diagnosis to social stigma.
0 Infographic: The pipeline for tuberculosis diagnostics
In this infographic we take a look at the diagnostics currently in the pipeline for tuberculosis, highlighting the stage of development and intended use.
1 Twitter chat for World TB Day #TalkTB
Join us for our Twitter chat with experts in the field on the 21st March at 11:00 EST / 15:00 GMT, discussing tuberculosis, its elimination and the challenges that face it #TalkTB.
0 Promising data for dolutegravir and HIV combination therapy GS-9620 and PGT121: industry news round-up
Partnership announcements and promising trial data reported at the 2018 Conference on Retroviruses and Opportunistic Infections, take a look at our round-up of the latest industry headlines.
0 Podcast: Tuberculosis and diagnosis – the week in infectious diseases
Listen to the top stories in infectious diseases this week, including novel CRISPR-based diagnostics, clinical trial in tuberculosis and the latest CDC approvals for the flu vaccine.
0 BCG revaccination and subunit vaccine offer hope in Phase II tuberculosis trial
A Phase II trial has suggested potential for new Bacille Calmette–Guerin revaccination strategies in addition to hope for subunit vaccines against tuberculosis.
0 About AMR: Leveraging host signaling pathways to control TB infections
In a recent study published in Nature Communications, researchers validated a novel screening approach to identify host-directed compounds that reduce the replication of intracellular pathogens, Julie Kaiser explains.
